MRK - Merck & Co., Inc.

NYSE - NYSE Delayed price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
48,081,000
46,840,000
42,294,000
40,122,000
39,807,000
Cost of revenue
14,372,000
14,112,000
13,509,000
12,775,000
13,891,000
Gross profit
33,709,000
32,728,000
28,785,000
27,347,000
25,916,000
Operating expenses
Research development
10,150,000
9,872,000
9,752,000
10,208,000
10,124,000
Selling general and administrative
10,745,000
10,615,000
10,102,000
9,830,000
9,762,000
Total operating expenses
20,895,000
20,487,000
19,854,000
20,038,000
19,886,000
Operating income or loss
12,814,000
12,241,000
8,931,000
7,309,000
6,030,000
Interest expense
896,000
893,000
772,000
754,000
693,000
Total other income/expenses net
107,000
-158,000
199,000
-419,000
-1,006,000
Income before tax
12,235,000
11,464,000
8,701,000
6,521,000
4,659,000
Income tax expense
2,101,000
1,687,000
2,508,000
4,103,000
718,000
Income from continuing operations
10,134,000
9,777,000
6,193,000
2,418,000
3,941,000
Net income
10,147,000
9,843,000
6,220,000
2,394,000
3,920,000
Net income available to common shareholders
10,147,000
9,843,000
6,220,000
2,394,000
3,920,000
Basic EPS
-
3.88
2.40
0.95
2.07
Diluted EPS
-
3.81
2.32
0.93
2.04
Basic average shares
-
2,539,016
2,592,560
2,696,612
2,748,731
Diluted average shares
-
2,580,000
2,679,000
2,748,000
2,787,000
EBITDA
-
16,009,000
13,992,000
11,912,000
10,793,000
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more